Comments
Loading...
Disc Medicine (IRON) Forecast
NewsEarningsDisc Medicine (IRON) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestDisc Medicine (NASDAQ:IRON) Stock Quotes, Forecast and News Summary
Disc Medicine Stock (NASDAQ: IRON) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Disc Medicine (IRON) stock?
You can purchase shares of Disc Medicine (NASDAQ:IRON) through any online brokerage.
Who are Disc Medicine (IRON) competitors?
Other companies in Disc Medicine’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Centessa Pharmaceuticals (NASDAQ:CNTA), Arcutis Biotherapeutics (NASDAQ:ARQT), Protagonist Therapeutics (NASDAQ:PTGX) and Mesoblast (NASDAQ:MESO).
What is the forecast, or price target, for Disc Medicine (IRON) stock?
Disc Medicine has a consensus price target of $70.27.
What is the current price for Disc Medicine (IRON)?
The stock price for Disc Medicine (NASDAQ: IRON) is $57.3 last updated January 15, 2025 at 7:59 AM EST.
Does Disc Medicine (IRON) pay a dividend?
There are no upcoming dividends for Disc Medicine.
When is Disc Medicine (NASDAQ:IRON) reporting earnings?
Disc Medicine’s Q4 earnings are confirmed for Thursday, March 20, 2025.
Is Disc Medicine (IRON) going to split?
There is no upcoming split for Disc Medicine.
What sector and industry does Disc Medicine (IRON) operate in?
Disc Medicine is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.